HCPLive Network

Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Further Reading
Combined biennial digital mammography and tomosynthesis screening is effective for women with dense breasts, according to a study published online Oct. 28 in Radiology.
Researchers have found that a simple blood test might help diagnose pancreatic cancer, one of the most deadly forms of the disease.
Laparoscopic interventions for rectal cancer are controversial. Oncologists have concerns about high conversion rates and long operating times associated with laparoscopic total mesorectal excision (TME), and they worry that laparoscopic TME violates the principle of sharp mesorectal dissection.
More Reading